Subsequent Events (Details) - Subsequent Event - USD ($) $ in Thousands |
Jun. 03, 2024 |
Feb. 05, 2024 |
May 03, 2024 |
---|---|---|---|
Biopharmaceutical Company | |||
Subsequent Event [Line Items] | |||
Initial proceeds from patent agreement | $ 500 | ||
Promissory Note | Individual Investor | |||
Subsequent Event [Line Items] | |||
Aggregate principal amount | $ 300 | ||
Interest rate, stated percentage | 6.00% | ||
Promissory Note | DGP Co. Ltd | Related Party | |||
Subsequent Event [Line Items] | |||
Aggregate principal amount | $ 700 | ||
Interest rate, stated percentage | 6.00% | ||
Debt term | 10 months |
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Proceeds From Patent License Agreement No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|